Q2 2017 Histogenics Corp Earnings Call

10/8/2017 8:30

Conference Call Histogenics Corp

Histogenics Corp Conference call or earnings call will be held on Aug 10, 2017 During the earnings conference call's session Histogenics Corp will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conference call the bridge access number and key in the PIN code, Contact Histogenics Corp for this information
Schedule a conference call with QCONF and get 5 free conference calls.
We are a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our first product candidate, NeoCart®, is being investigated in a Phase 3 clinical trial. NeoCart utilizes various aspects of our regenerative medicine platform to develop an innovative tissue implant intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. Joint, or articular, cartilage covers the ends of bones and allows for joints to glide smoothly with minimal friction. Cartilage damage, or chondral defects, can be caused by acute trauma, such as a bad fall or sports-related injury, or by repetitive trauma, such as general wear over time. Unlike other tissues in the body, joint cartilage has no innate ability to repair itself, making any injury permanent.    
Read more Conference Call

Histogenics Corp (HSGX)

830 Winter Street, Waltham Massachusetts 02451, United States